A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

A Phase 4, Open Label Study To Assess The Bronchopulmonary Pharmacokinetics Of Anidulafungin And Voriconazole Following Intravenous Administration In Healthy Subjects

The purpose of this study is to provide anidulafungin and voriconazole to healthy subjects to determine the drug concentration in the lung.

Inclusion Criteria:

• Healthy adult subjects willing to comply with the study requirement.

Exclusion Criteria:

• Clinical significant disease.
• Sensitive to study medication.
• Not willing to comply with the study requirement.